#obicetrapib
Obicetrapib
Chemical compound
Obicetrapib is an experimental CETP inhibitor that is intended to treat dyslipidemia. In a clinical trial, as an add-on to statins, compared with placebo, it decreased concentrations of LDL-C, apolipoprotein B and non-high-density lipoprotein cholesterol (non-HDL-C), and increased HDL-C concentration. As of 2023, it is in a Phase III trial.
Mon 20th
Provided by Wikipedia
This keyword could refer to multiple things. Here are some suggestions:
0 searches
This keyword has never been searched before
This keyword has never been searched for with any other keyword.